Ultibro® Versus Spiriva® Alone to Reduce Exertional Dyspnea in Patients With Moderate to Severe COPD

NCT02567214 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

50

Enrollment

OTHER

Sponsor class

Conditions

COPD

Interventions

DRUG: Ultibro®
DRUG: Spiriva®

Sponsor

Laval University

Collaborators

[object Object]